Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the United States [7]

AIDS

Volumn 20, Issue 3, 2006, Pages 475-478

  Singh, Kumud K ^a   Hughes, Michael D ^c   Chen, Jie ^c   Spector, Stephen A ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MONOCYTE CHEMOTACTIC PROTEIN 1;

AGE DISTRIBUTION; ALLELE; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; COMPARATIVE STUDY; DISEASE COURSE; ETHNIC DIFFERENCE; ETHNOLOGY; FOLLOW UP; GENOTYPE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; IMMUNOPATHOGENESIS; LETTER; NEGRO; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PROTEIN VARIANT; RACE DIFFERENCE; UNITED STATES;

CHEMOKINE CCL2; CHILD; CHILD, PRESCHOOL; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; UNITED STATES;

EID: 33645038567     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000200540.09856.58     Document Type: Letter

References (19)

1. Michael NL. Host genetic influences on HIV-1 pathogenesis. Curr Opin Immunol 1999; 11:466-474.
2. Paxton WA, Kang S. Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression. Semin Immunol 1998; 10:187-194.
3. Kostrikis LG, Neumann AU, Thomson B, Korber BT, McHardy P, Karanicolas R, et al. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol 1999; 73:10264-10271.
4. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998; 4:350-353.
5. Singh KK, Barroga CF, Hughes MD, Chen J, Raskino C, McKinney RE, et al. Genetic influence of CCR5, CCR2 and SDF1 variants on HIV-1 related disease progression and neurological impairment in children with symptomatic HIV-1 infection. J Infect Dis 2003; 188:1461-1472.
6. Glabinski AR, Tani M, Aras S, Stoler MH, Tuohy VK, Ransohoff RM. Regulation and function of central nervous system chemokines. Int J Dev Neurosci 1995; 13:153-165.
7. Cinque P, Vago L, Mengozzi M, Torri V, Ceresa D, Vicenzi E, et al. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 1998; 12:1327-1332.
8. Gu L, Tseng SC, Rollins BJ. Monocyte chemoattractant protein-1. Chem Immunol 1999; 72:7-29.
9. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, Mummidi S, et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A 2002; 99:13795-13800.
10. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997; 277:959-965.
11. van Rij RP, de Roda Husman AM, Brouwer M, Goudsmit J, Coutinho RA, Schuitemaker H. Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants. J Infect Dis 1998; 178:1806-1811.
12. Michael NL, Louie LG, Rohrbaugh AL, Schultz KA, Dayhoff DE, Wang CE, et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med 1997; 10:1160-1162.
13. Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, et al. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection. AIDS 2003; 17:377-387.
14. Englund JA, Baker CJ, Raskino C, McKinney RE, Lifschitz MH, Petrie B, et al. Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children, AIDS Clinical Trials Group Protocol 152 Study Team. Pediatr Infect Dis J 1996; 15:1025-1036.
15. McKinney RE Jr, Johnson GM, Stanley K, Yong FH, Keller A, O'Donnell KJ, et al. A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy naive HIV-1 infection. The Pediatric AIDS Clinical Trials Group Protocol 300 Study Team. J Pediatr 1998; 133:500-508.
16. Singh KK, Ellis RJ, Marquie-Beck J, Letendre S, Heaton RK, Grant I, et al. CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. J Neuroimmunol 2004; 157:185-192.
17. Singh KK, Hughes MD, Chen J, Spector SA. Genetic polymorphisms in CX3CR1 predict HIV-1 disease progression in children independently of CD4+ lymphocyte count and HIV-1 RNA load. J Infect Dis 2005; 191:1971-1980.
18. Lee B, Doranz BJ, Rana S, Yi Y, Mellado M, Frade JM, et al. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol 1998; 72:7450-7458.
19. Mariani R, Wong S, Mulder LC, Wilkinson DA, Reinhart AL, LaRosa G, et al. CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function. J Virol 1999; 73:2450-2459.